Eli Lilly’s Reyvow, squaring off against AbbVie and Biohaven, posts data showing early and lasting migraine relief esagonowsky […]

AstraZeneca changes minds at NICE, winning Tagrisso coverage in 2 lung cancer indications aliu Fri, 09/11/2020 – 11:13

Roche’s Ocrevus touts 2-year switching data in jam-packed—and growing—multiple sclerosis market kblankenship Fri, 09/11/2020 – 10:57

FDA leaders, facing doubts over the agency’s independence, pledge to ‘follow the science’ amid pandemic esagonowsky Fri, 09/11/2020 […]

Pfizer, Novartis and others return to Facebook after hate speech boycott, but plan to keep tabs on changes […]

The drug’s use has, however, been restricted to reversing anticoagulation from apixaban or rivaroxaban in adults with life […]

The drug reduced the size of nasal polyps and reduced nasal blockage

The blood test reliably picks up mutations in breast cancer and matches women to different targeted treatments, researchers […]

The projects are investigating different aspects of virus transmission in the hope that findings will better inform policy […]

Many diseases require IV infusion therapy. But uncontrolled infusion rates and incorrect dosing can lead to severe complications […]